Journal Mobile Options
Table of Contents
Vol. 30, No. 2, 1982
Issue release date: 1982
Add to my selection Citation Download
Nephron 1982;30:143–148
(DOI:10.1159/000182451)
Original Paper

The Role of Parathyroidectomy in the Management of Hyperparathyroidism in Patients on Maintenance Haemodialysis and After Renal Transplantation

Memmos D.E. · Williams G.B. · Eastwood J.B. · Gordon E.M. · Cochrane C.L. · Gower P.E. · Curtis J.R. · Phillips M.E. · Rainford D.J. · de Wardener H.E.
Departments of Medicine and Urology, Charing Cross Hospital Medical School, London, England Nephron 1982;30:143–148 (DOI:10.1159/000182451)

Abstract

Between March 1964 and March 1980, 36 (34 dialysis, 2 transplant) of 327 patients accepted for the maintenance dialysis/transplantation programme at Charing Cross Hospital were submitted to parathyroidectomy. There were four main indications: persistent hypercalcaemia, progressive phalangeal erosions, aseptic necrosis of the femoral head and height loss with abnormal bone biopsy despite normal hand radiographs. At parathyroidectomy, 4 glands were removed in 1 patient, 3 ½ glands in 24, 3 glands in 7, 2 glands in 3 and a single large gland in 1 patient. The operation was followed by improvement in 28 patients, no change in 5, and progression of hyperparathyroidism in 3. 2 of the 28 patients who improved later relapsed and were treated with 1,25-(OH)2 vitamin D3. 4 patients were submitted to a further parathyroidectomy and improved considerably. We would conclude that, although parathyroidectomy is an effective and safe procedure, it is to be hoped that careful monitoring of bone state and early administration of 1,25-(OH)2 vitamin D3 may reduce the need for parathyroidectomy.

 goto top of outline Author Contacts

Prof. H. E. de Wardener, Department of Medicine, Charing Cross Hospital, Fulham Palace Road, London W6 8RF (England)


 goto top of outline Article Information

Accepted: May 18, 1981
Published online: December 03, 2008
Number of Print Pages : 6


 goto top of outline Publication Details

Nephron

Vol. 30, No. 2, Year 1982 (Cover Date: 1982)

Journal Editor: Fine L.G. (Los Angeles, Calif.)
ISSN: 0028–2766 (Print), eISSN: 1423–0186 (Online)

For additional information: http://www.karger.com/NEF


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.